4//SEC Filing
Arnold Jonathan 4
Accession 0001596783-23-000092
CIK 0001596783other
Filed
Aug 24, 8:00 PM ET
Accepted
Aug 25, 6:56 PM ET
Size
7.2 KB
Accession
0001596783-23-000092
Insider Transaction Report
Form 4
Catalent, Inc.CTLT
Arnold Jonathan
President, Oral Drug Delivery
Transactions
- Award
Common Stock
2023-08-23+1,590→ 57,486 total - Sale
Common Stock
2023-08-24$44.87/sh−87$3,904→ 57,399 total
Footnotes (4)
- [F1]Received upon the achievement of the fiscal 2021-23 performance-based vesting criteria set forth in certain incentive compensation held by the reporting person under the Issuer's long-term incentive plan.
- [F2]Includes restricted stock units.
- [F3]Shares sold by the reporting person through an automatic "sell to cover" transaction in order to cover tax withholding obligations in connection with the vesting of performance share units received pursuant to the Issuer's long-term incentive plan. No shares were withheld by or surrendered to the Issuer.
- [F4]Volume-weighted average price. These shares were sold in multiple transactions at prices ranging from $44.64 to $45.18, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
Catalent, Inc.
CIK 0001596783
Entity typeother
Related Parties
1- filerCIK 0001721336
Filing Metadata
- Form type
- 4
- Filed
- Aug 24, 8:00 PM ET
- Accepted
- Aug 25, 6:56 PM ET
- Size
- 7.2 KB